Evidence map›Paper›PMID 41051703›Full record

ArticleAnnals of intensive care2025

Tidal volume and mortality during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a multicenter observational cohort study.

Torben M Rixecker, Jeannine L Kühnle, Johannes Herrmann, Christopher Lotz, Christian Kühn, Frederik Seiler, Carlos Metz, Armin Kalenka, Oxana Mazuru, Kai Borchardt and 7 more

Abstract read
In one paragraph

Article in Annals of intensive care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Torben M Rixecker *Department of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany. torben.rixecker@uks.eu.ORCID http://orcid.org/0000-0003-1417-7571
Jeannine L Kühnle *Department of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Johannes HerrmannDepartment of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO center, University Hospital Würzburg, Kliniken der Stadt Köln, Cologne, Germany.
Christopher LotzDepartment of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO center, University Hospital Würzburg, Kliniken der Stadt Köln, Cologne, Germany.
Christian KühnDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Frederik SeilerDepartment of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Carlos MetzDepartment of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Armin KalenkaRegional Hospital, Kreiskrankenhaus Bergstrasse, Heppenheim, Germany.
Oxana MazuruDepartment of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Kai BorchardtDepartment of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Ralf M MuellenbachDepartment of Anesthesiology and Critical Care Medicine, ARDS/ECMO-Center, Campus Kassel of the University of Southampton, Kassel, Germany.
Robert BalsDepartment of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Matthieu SchmidtSorbonne University, GRC RESPIRE, Medical Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
Patrick MeybohmDepartment of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO center, University Hospital Würzburg, Kliniken der Stadt Köln, Cologne, Germany.
Vitalie Mazuru *Department of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
Philipp M Lepper *Department of Internal Medicine V (Pneumology, Allergology and Intensive Care Medicine), Saarland University, Kirrberger Str. 100, 66421, Homburg, Germany.
German ECMO COVID Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApproximately half of the patients with acute respiratory distress syndrome (ARDS) receiving extracorporeal membrane oxygenation (ECMO) remain ECMO-dependent beyond 14 days after ECMO initiation. The identification of factors associated with mortality during an ECMO run may update prognostic assessment and focus clinical interventions.

methodsIn this observational study, data from 1137 patients with COVID-19 ARDS receiving ECMO support in 29 German centers between January 1st 2020 and July 31st 2021 were analyzed. Multivariable stepwise logistic regression analyses were performed to build survival prediction models with day-by-day data during the first 14 days of an ECMO run. The primary endpoint was all-cause mortality in the intensive care unit.

resultsMortality in this cohort was high (75%). Patients who remained ECMO-dependent on day 14 of their ECMO run showed comparable mortality to all patients receiving ECMO support on day 1. Yet, factors associated with mortality changed during the first 14 days of ECMO support. On day 1 of ECMO support, only patient age and lactate remained in the final mortality prediction model. On day 14 of an ECMO run, tidal volume was independently associated with mortality (adjusted Odds Ratio 0.693 (95%CI 0.564-0.851), p < 0.001 for 1 mL/kg increase in tidal volume per predicted body weight). The adjusted mortality for patients with a tidal volume below 2 mL/kg on day 14 of their ECMO run was above 80% (lower limit of the 95%CI interval). Higher tidal volume was mainly based on higher respiratory system compliance. Yet, the benefit of higher compliance was not observed in some patients who were still ventilated with very low driving pressures despite remaining ECMO-dependent on day 14 of ECMO support.

conclusionsMortality predictors change during the course of an ECMO run. In a cohort with high mortality, on day 14 of ECMO support for ARDS, tidal volume may be an independent predictor of mortality. Further analyses on ventilation strategies in patients who remain ECMO-dependent are needed. TRIAL REGISTRATION NUMBER: DRKS00022964, retrospectively registered.

Indexed as

ARDSECMOMortality prediction

Identifiers

PMID41051703
PMCPMC12500509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.